FDAnews
www.fdanews.com/articles/122280-galapagos-initiates-phase-ii-trial-for-multiple-sclerosis

Galapagos Initiates Phase II Trial for Multiple Sclerosis

November 17, 2009
Galapagos NV announced that it has started a Phase II clinical study to evaluate Nanocort’s effectiveness in treating flares in multiple sclerosis.
CNNMoney